GSI 7977 (Sovaldi 400 mg)
Generic Name: sofosbuvir
Pill with imprint GSI 7977 is Yellow, Capsule-shape and has been identified as Sovaldi 400 mg. It is supplied by Gilead Sciences, Inc.
Sovaldi is used in the treatment of hepatitis c and belongs to the drug class miscellaneous antivirals. There is no proven risk in humans during pregnancy. in combination with Ribavirin or Peginterferon Alfa/Ribavirin: Not for use in pregnancy. Sovaldi 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 7977
Sovaldi
- Generic Name
- sofosbuvir
- Imprint
- GSI 7977
- Strength
- 400 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous antivirals
- Pregnancy Category
- B - No proven risk in humans, X - Not for use in pregnancy - in combination with Ribavirin or Peginterferon Alfa/Ribavirin
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-1501
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
croscarmellose sodium,
silicon dioxide,
magnesium stearate,
titanium dioxide,
magnesium silicate,
ferric oxide yellow,
water
Note: Inactive ingredients may vary.
More about Sovaldi (sofosbuvir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (47)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: miscellaneous antivirals
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.